Arena Pharmaceutical (ARNA) Reports Q3 Loss, Lowers 2006 Revenue Outlook
Tweet Send to a Friend
Arena Pharmaceutical (Nasdaq: ARNA) reports a Q3 loss of $0.43, versus the consensus ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE